LSM4 as a potential prognostic indicator and therapeutic target in triple-negative breast cancer progression
Our findings indicate that LSM4 can play a crucial role in TNBC progression, underscoring its potential as a therapeutic target in TNBC.
Authors
- Yifan Li (ORCID: https://orcid.org/0000-0003-1470-8862)
- Nannan Zhang (ORCID: https://orcid.org/0000-0002-4583-3095)
- Feiran Wang (ORCID: https://orcid.org/0000-0002-1790-7130)
- Xiaobing Yang
- Zhen Ren (ORCID: https://orcid.org/0000-0003-1979-7040)
- Zhixian He
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Huaian First People’s Hospital (CN)
Publication Details
- Journal
- Gland Surgery
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/gs-2025-48
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00